Alex Goldsmith

Alex Goldsmith - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Alex Goldsmith’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
Contacts
Emailfir***@***.comLinkedin Available after registration.
Markets
Past investments
KSQ TherapeuticsDenali TherapeuticsSyros PharmaceuticalsIncredible FoodsInzen TherapeuticsOhana BiosciencesT2 BiosystemsTangent Medical TechnologiesKaleido BioSciencesPermeon BiologicsKovioOasys WaterEditas MedicineTessera TherapeuticsRing TherapeuticsModerna TherapeuticsOmega TherapeuticsCygnal TherapeuticsSana BiotechnologySeres TherapeuticsAgios PharmaceuticalsRed Rock BiofuelsTarveda TherapeuticsReceptosRepertoire Immune MedicinesGenerate BiomedicinesCodiak BiosciencesBlackDuckPolatisSeventh Sense BiosystemsSigilon TherapeuticsBoragenTARIS BiomedicalTransMedicsSelecta BiosciencesQuanterixVisterraSesen Bio, Inc.CiBO TechnologiesmedidametricsRubius TherapeuticsAxcellaSenda BiosciencesFoghorn TherapeuticsEvelo BiosciencesInariJoule Unlimited TechnologiesCellarityWikiCell DesignsAvedroIndigoEcoSense LightingPfizerValo HealthInvaio Sciences
Investor Profile

Alex Goldsmith is a Venture Capital, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciences, Permeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera Therapeutics, Ring Therapeutics, Moderna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedics, Selecta Biosciences, Quanterix, Visterra, Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn TherapeuticsEvelo Biosciences, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, Pfizer, Valo Health, Invaio Sciences, . Over time, Alex Goldsmith has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alex Goldsmith is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Clean Tech, Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Healthcare Innovation, Strategic Partnerships, Life Science, Engineering, Science, Venture Fundraising, Biotechnology, Medical Devices, Drug Development, Hispanic / Latinx Founded, Clean Technology, Entrepreneurship, Electronic Health Records (EHR), Health and Hospital Services, Innovation, Clinical Trials, Groceries, Disruptive technology, Research, Agriculture, Personalized Medicine, Oil and Gas, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Health Tech, Machine Learning, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Alex Goldsmith, as their portfolio suggests a familiarity and interest in this area.

Understanding Alex Goldsmith’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today